Marchés français ouverture 3 h 30 min
  • Dow Jones

    28 335,57
    -28,13 (-0,10 %)
     
  • Nasdaq

    11 548,28
    +42,28 (+0,37 %)
     
  • Nikkei 225

    23 484,53
    -32,06 (-0,14 %)
     
  • EUR/USD

    1,1840
    -0,0028 (-0,24 %)
     
  • HANG SENG

    24 918,78
    +132,68 (+0,54 %)
     
  • BTC-EUR

    11 045,57
    -7,45 (-0,07 %)
     
  • CMC Crypto 200

    262,98
    +1,52 (+0,58 %)
     
  • S&P 500

    3 465,39
    +11,90 (+0,34 %)
     

Global Critical Care Therapeutics Industry

ReportLinker
·24 min de lecture

Global Critical Care Therapeutics Market to Reach $3. 5 Billion by 2027. Amid the COVID-19 crisis, the global market for Critical Care Therapeutics estimated at US$2. 9 Billion in the year 2020, is projected to reach a revised size of US$3.

New York, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Critical Care Therapeutics Industry" - https://www.reportlinker.com/p05956486/?utm_source=GNW
5 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Albumin, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 2.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $785.8 Million, While China is Forecast to Grow at 4.9% CAGR

The Critical Care Therapeutics market in the U.S. is estimated at US$785.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$700.3 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Antithrombin Concentrates Segment to Record 2.3% CAGR

In the global Antithrombin Concentrates segment, USA, Canada, Japan, China and Europe will drive the 1.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$260.9 Million in the year 2020 will reach a projected size of US$298 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$475 Million by the year 2027, while Latin America will expand at a 3.2% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 280-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abeona Therapeutics Inc.

  • ADMA Biologics, Inc.

  • Albumedix Ltd.

  • Asklepios Biopharmaceutical, Inc.

  • Aspen Pharmacare Holdings Ltd.

  • Baxter International Inc.

  • Bayer Healthcare AG

  • Bio Products Laboratory Ltd.

  • BioDelivery Sciences International, Inc.

  • Biogen, Inc.

  • BioMarin Pharmaceutical Inc.

  • Biotest Pharmaceuticals Corporation

  • Bristol-Myers Squibb Company

  • Catalyst Biosciences, Inc.

  • China Biologic Products Holdings, Inc.

  • Cosmo Pharmaceuticals NV

  • CSL Behring

  • Grifols International SA

  • Kamada Ltd.

  • Kedrion Biopharma, Inc.

  • Medxbio Pte. Ltd.

  • Merck & Co., Inc.

  • Mitsubishi Tanabe Pharma Corporation

  • Novo Nordisk A/S

  • Novozymes A/S

  • Octapharma AG

  • Portola Pharmaceuticals, Inc.

  • ProMetic Life Sciences, Inc.

  • rEVO Biologics, Inc.

  • Rockwell Medical

  • Sanquin

  • Shanghai RAAS Blood Products Co., Ltd.

  • Shire PLC

  • Teva Pharmaceutical Industries Ltd.

  • The Medicines Company

  • Thermo Fisher Scientific, Inc.

  • Ventria Bioscience




Read the full report: https://www.reportlinker.com/p05956486/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Critical Care Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Critical Care Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Critical Care Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Critical Care Therapeutics Market Share Shift across
Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Albumin (Drug Class) World Market by Region/Country in
US$ Million: 2020 to 2027

Table 5: Albumin (Drug Class) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Albumin (Drug Class) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Prothrombin Complex Concentrates (Drug Class)
Potential Growth Markets Worldwide in US$ Million: 2020 to 2027

Table 8: Prothrombin Complex Concentrates (Drug Class) Historic
Market Perspective by Region/Country in US$ Million: 2012 to
2019

Table 9: Prothrombin Complex Concentrates (Drug Class) Market
Sales Breakdown by Region/Country in Percentage: 2012 VS 2020
VS 2027

Table 10: Antithrombin Concentrates (Drug Class) Geographic
Market Spread Worldwide in US$ Million: 2020 to 2027

Table 11: Antithrombin Concentrates (Drug Class) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2012 to
2019

Table 12: Antithrombin Concentrates (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 13: Other Drug Classes (Drug Class) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027

Table 14: Other Drug Classes (Drug Class) Market Historic
Review by Region/Country in US$ Million: 2012 to 2019

Table 15: Other Drug Classes (Drug Class) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 16: Deep Vein Thrombosis (Application) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2020-2027

Table 17: Deep Vein Thrombosis (Application) Global Historic
Analysis in US$ Million by Region/Country: 2012-2019

Table 18: Deep Vein Thrombosis (Application) Distribution of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

Table 19: Pulmonary Embolism (PE) (Application) Sales Estimates
and Forecasts in US$ Million by Region/Country for the Years
2020 through 2027

Table 20: Pulmonary Embolism (PE) (Application) Analysis of
Historic Sales in US$ Million by Region/Country for the Years
2012 to 2019

Table 21: Pulmonary Embolism (PE) (Application) Global Market
Share Distribution by Region/Country for 2012, 2020, and 2027

Table 22: Acute Coronary Syndrome (Application) Global
Opportunity Assessment in US$ Million by Region/Country:
2020-2027

Table 23: Acute Coronary Syndrome (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 24: Acute Coronary Syndrome (Application) Percentage
Share Breakdown of Global Sales by Region/Country: 2012 VS 2020
VS 2027

Table 25: Other Applications (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027

Table 26: Other Applications (Application) Historic Demand
Patterns in US$ Million by Region/Country: 2012-2019

Table 27: Other Applications (Application) Market Share Shift
across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Critical Care Therapeutics Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 28: United States Critical Care Therapeutics Market
Estimates and Projections in US$ Million by Drug Class: 2020 to
2027

Table 29: Critical Care Therapeutics Market in the United
States by Drug Class: A Historic Review in US$ Million for
2012-2019

Table 30: United States Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 31: United States Critical Care Therapeutics Latent
Demand Forecasts in US$ Million by Application: 2020 to 2027

Table 32: Critical Care Therapeutics Historic Demand Patterns
in the United States by Application in US$ Million for
2012-2019

Table 33: Critical Care Therapeutics Market Share Breakdown in
the United States by Application: 2012 VS 2020 VS 2027

CANADA
Table 34: Canadian Critical Care Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Class: 2020 to 2027

Table 35: Canadian Critical Care Therapeutics Historic Market
Review by Drug Class in US$ Million: 2012-2019

Table 36: Critical Care Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Drug Class for 2012,
2020, and 2027

Table 37: Canadian Critical Care Therapeutics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 38: Critical Care Therapeutics Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 39: Canadian Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

JAPAN
Table 40: Japanese Market for Critical Care Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2020-2027

Table 41: Critical Care Therapeutics Market in Japan: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2012-2019

Table 42: Japanese Critical Care Therapeutics Market Share
Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 43: Japanese Demand Estimates and Forecasts for Critical
Care Therapeutics in US$ Million by Application: 2020 to 2027

Table 44: Japanese Critical Care Therapeutics Market in US$
Million by Application: 2012-2019

Table 45: Critical Care Therapeutics Market Share Shift in
Japan by Application: 2012 VS 2020 VS 2027

CHINA
Table 46: Chinese Critical Care Therapeutics Market Growth
Prospects in US$ Million by Drug Class for the Period 2020-2027

Table 47: Critical Care Therapeutics Historic Market Analysis
in China in US$ Million by Drug Class: 2012-2019

Table 48: Chinese Critical Care Therapeutics Market by Drug
Class: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 49: Chinese Demand for Critical Care Therapeutics in US$
Million by Application: 2020 to 2027

Table 50: Critical Care Therapeutics Market Review in China in
US$ Million by Application: 2012-2019

Table 51: Chinese Critical Care Therapeutics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Critical Care Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 52: European Critical Care Therapeutics Market Demand
Scenario in US$ Million by Region/Country: 2020-2027

Table 53: Critical Care Therapeutics Market in Europe:
A Historic Market Perspective in US$ Million by Region/Country
for the Period 2012-2019

Table 54: European Critical Care Therapeutics Market Share
Shift by Region/Country: 2012 VS 2020 VS 2027

Table 55: European Critical Care Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Class: 2020-2027

Table 56: Critical Care Therapeutics Market in Europe in US$
Million by Drug Class: A Historic Review for the Period
2012-2019

Table 57: European Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 58: European Critical Care Therapeutics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 59: Critical Care Therapeutics Market in Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 60: European Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

FRANCE
Table 61: Critical Care Therapeutics Market in France by Drug
Class: Estimates and Projections in US$ Million for the Period
2020-2027

Table 62: French Critical Care Therapeutics Historic Market
Scenario in US$ Million by Drug Class: 2012-2019

Table 63: French Critical Care Therapeutics Market Share
Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 64: Critical Care Therapeutics Quantitative Demand
Analysis in France in US$ Million by Application: 2020-2027

Table 65: French Critical Care Therapeutics Historic Market
Review in US$ Million by Application: 2012-2019

Table 66: French Critical Care Therapeutics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

GERMANY
Table 67: Critical Care Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2020-2027

Table 68: German Critical Care Therapeutics Historic Market
Analysis in US$ Million by Drug Class: 2012-2019

Table 69: German Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 70: Critical Care Therapeutics Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 71: German Critical Care Therapeutics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 72: Critical Care Therapeutics Market Share Distribution
in Germany by Application: 2012 VS 2020 VS 2027

ITALY
Table 73: Italian Critical Care Therapeutics Market Growth
Prospects in US$ Million by Drug Class for the Period 2020-2027

Table 74: Critical Care Therapeutics Historic Market Analysis
in Italy in US$ Million by Drug Class: 2012-2019

Table 75: Italian Critical Care Therapeutics Market by Drug
Class: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 76: Italian Demand for Critical Care Therapeutics in US$
Million by Application: 2020 to 2027

Table 77: Critical Care Therapeutics Market Review in Italy in
US$ Million by Application: 2012-2019

Table 78: Italian Critical Care Therapeutics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 79: United Kingdom Market for Critical Care Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2020-2027

Table 80: Critical Care Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Drug Class
for the Period 2012-2019

Table 81: United Kingdom Critical Care Therapeutics Market
Share Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 82: United Kingdom Demand Estimates and Forecasts for
Critical Care Therapeutics in US$ Million by Application: 2020
to 2027

Table 83: United Kingdom Critical Care Therapeutics Market in
US$ Million by Application: 2012-2019

Table 84: Critical Care Therapeutics Market Share Shift in the
United Kingdom by Application: 2012 VS 2020 VS 2027

SPAIN
Table 85: Spanish Critical Care Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Class: 2020 to 2027

Table 86: Spanish Critical Care Therapeutics Historic Market
Review by Drug Class in US$ Million: 2012-2019

Table 87: Critical Care Therapeutics Market in Spain:
Percentage Share Breakdown of Sales by Drug Class for 2012,
2020, and 2027

Table 88: Spanish Critical Care Therapeutics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 89: Critical Care Therapeutics Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 90: Spanish Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

RUSSIA
Table 91: Russian Critical Care Therapeutics Market Estimates
and Projections in US$ Million by Drug Class: 2020 to 2027

Table 92: Critical Care Therapeutics Market in Russia by Drug
Class: A Historic Review in US$ Million for 2012-2019

Table 93: Russian Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 94: Russian Critical Care Therapeutics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 95: Critical Care Therapeutics Historic Demand Patterns
in Russia by Application in US$ Million for 2012-2019

Table 96: Critical Care Therapeutics Market Share Breakdown in
Russia by Application: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 97: Rest of Europe Critical Care Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Class: 2020-2027

Table 98: Critical Care Therapeutics Market in Rest of Europe
in US$ Million by Drug Class: A Historic Review for the Period
2012-2019

Table 99: Rest of Europe Critical Care Therapeutics Market
Share Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 100: Rest of Europe Critical Care Therapeutics
Addressable Market Opportunity in US$ Million by Application:
2020-2027

Table 101: Critical Care Therapeutics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 102: Rest of Europe Critical Care Therapeutics Market
Share Analysis by Application: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Critical Care Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 104: Critical Care Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 105: Asia-Pacific Critical Care Therapeutics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 106: Critical Care Therapeutics Market in Asia-Pacific by
Drug Class: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 107: Asia-Pacific Critical Care Therapeutics Historic
Market Scenario in US$ Million by Drug Class: 2012-2019

Table 108: Asia-Pacific Critical Care Therapeutics Market Share
Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 109: Critical Care Therapeutics Quantitative Demand
Analysis in Asia-Pacific in US$ Million by Application:
2020-2027

Table 110: Asia-Pacific Critical Care Therapeutics Historic
Market Review in US$ Million by Application: 2012-2019

Table 111: Asia-Pacific Critical Care Therapeutics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

AUSTRALIA
Table 112: Critical Care Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2020-2027

Table 113: Australian Critical Care Therapeutics Historic
Market Analysis in US$ Million by Drug Class: 2012-2019

Table 114: Australian Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 115: Critical Care Therapeutics Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 116: Australian Critical Care Therapeutics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 117: Critical Care Therapeutics Market Share Distribution
in Australia by Application: 2012 VS 2020 VS 2027

INDIA
Table 118: Indian Critical Care Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Class: 2020 to 2027

Table 119: Indian Critical Care Therapeutics Historic Market
Review by Drug Class in US$ Million: 2012-2019

Table 120: Critical Care Therapeutics Market in India:
Percentage Share Breakdown of Sales by Drug Class for 2012,
2020, and 2027

Table 121: Indian Critical Care Therapeutics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 122: Critical Care Therapeutics Market in India:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 123: Indian Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 124: Critical Care Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2020-2027

Table 125: South Korean Critical Care Therapeutics Historic
Market Analysis in US$ Million by Drug Class: 2012-2019

Table 126: Critical Care Therapeutics Market Share Distribution
in South Korea by Drug Class: 2012 VS 2020 VS 2027

Table 127: Critical Care Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Application for the Period 2020-2027

Table 128: South Korean Critical Care Therapeutics Historic
Market Analysis in US$ Million by Application: 2012-2019

Table 129: Critical Care Therapeutics Market Share Distribution
in South Korea by Application: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Market for Critical Care
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Drug Class for the Period 2020-2027

Table 131: Critical Care Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Class for the Period 2012-2019

Table 132: Rest of Asia-Pacific Critical Care Therapeutics
Market Share Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Critical Care Therapeutics in US$ Million by Application:
2020 to 2027

Table 134: Rest of Asia-Pacific Critical Care Therapeutics
Market in US$ Million by Application: 2012-2019

Table 135: Critical Care Therapeutics Market Share Shift in
Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 136: Latin American Critical Care Therapeutics Market
Trends by Region/Country in US$ Million: 2020-2027

Table 137: Critical Care Therapeutics Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2012-2019

Table 138: Latin American Critical Care Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 139: Latin American Critical Care Therapeutics Market
Growth Prospects in US$ Million by Drug Class for the Period
2020-2027

Table 140: Critical Care Therapeutics Historic Market Analysis
in Latin America in US$ Million by Drug Class: 2012-2019

Table 141: Latin American Critical Care Therapeutics Market by
Drug Class: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 142: Latin American Demand for Critical Care Therapeutics
in US$ Million by Application: 2020 to 2027

Table 143: Critical Care Therapeutics Market Review in Latin
America in US$ Million by Application: 2012-2019

Table 144: Latin American Critical Care Therapeutics Market
Share Breakdown by Application: 2012 VS 2020 VS 2027

ARGENTINA
Table 145: Argentinean Critical Care Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Class: 2020-2027

Table 146: Critical Care Therapeutics Market in Argentina in
US$ Million by Drug Class: A Historic Review for the Period
2012-2019

Table 147: Argentinean Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 148: Argentinean Critical Care Therapeutics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 149: Critical Care Therapeutics Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 150: Argentinean Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

BRAZIL
Table 151: Critical Care Therapeutics Market in Brazil by Drug
Class: Estimates and Projections in US$ Million for the Period
2020-2027

Table 152: Brazilian Critical Care Therapeutics Historic Market
Scenario in US$ Million by Drug Class: 2012-2019

Table 153: Brazilian Critical Care Therapeutics Market Share
Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 154: Critical Care Therapeutics Quantitative Demand
Analysis in Brazil in US$ Million by Application: 2020-2027

Table 155: Brazilian Critical Care Therapeutics Historic Market
Review in US$ Million by Application: 2012-2019

Table 156: Brazilian Critical Care Therapeutics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

MEXICO
Table 157: Critical Care Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2020-2027

Table 158: Mexican Critical Care Therapeutics Historic Market
Analysis in US$ Million by Drug Class: 2012-2019

Table 159: Mexican Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 160: Critical Care Therapeutics Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 161: Mexican Critical Care Therapeutics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 162: Critical Care Therapeutics Market Share Distribution
in Mexico by Application: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 163: Rest of Latin America Critical Care Therapeutics
Market Estimates and Projections in US$ Million by Drug Class:
2020 to 2027

Table 164: Critical Care Therapeutics Market in Rest of Latin
America by Drug Class: A Historic Review in US$ Million for
2012-2019

Table 165: Rest of Latin America Critical Care Therapeutics
Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 166: Rest of Latin America Critical Care Therapeutics
Latent Demand Forecasts in US$ Million by Application: 2020 to
2027

Table 167: Critical Care Therapeutics Historic Demand Patterns
in Rest of Latin America by Application in US$ Million for
2012-2019

Table 168: Critical Care Therapeutics Market Share Breakdown in
Rest of Latin America by Application: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 169: The Middle East Critical Care Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 170: Critical Care Therapeutics Market in the Middle East
by Region/Country in US$ Million: 2012-2019

Table 171: The Middle East Critical Care Therapeutics Market
Share Breakdown by Region/Country: 2012, 2020, and 2027

Table 172: The Middle East Critical Care Therapeutics Market
Estimates and Forecasts in US$ Million by Drug Class: 2020 to
2027

Table 173: The Middle East Critical Care Therapeutics Historic
Market by Drug Class in US$ Million: 2012-2019

Table 174: Critical Care Therapeutics Market in the Middle
East: Percentage Share Breakdown of Sales by Drug Class for
2012,2020, and 2027

Table 175: The Middle East Critical Care Therapeutics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 176: Critical Care Therapeutics Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by Application for 2012-2019

Table 177: The Middle East Critical Care Therapeutics Market
Share Analysis by Application: 2012 VS 2020 VS 2027

IRAN
Table 178: Iranian Market for Critical Care Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2020-2027

Table 179: Critical Care Therapeutics Market in Iran: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2012-2019

Table 180: Iranian Critical Care Therapeutics Market Share
Analysis by Drug Class: 2012 VS 2020 VS 2027

Table 181: Iranian Demand Estimates and Forecasts for Critical
Care Therapeutics in US$ Million by Application: 2020 to 2027

Table 182: Iranian Critical Care Therapeutics Market in US$
Million by Application: 2012-2019

Table 183: Critical Care Therapeutics Market Share Shift in
Iran by Application: 2012 VS 2020 VS 2027

ISRAEL
Table 184: Israeli Critical Care Therapeutics Market Estimates
and Forecasts in US$ Million by Drug Class: 2020-2027

Table 185: Critical Care Therapeutics Market in Israel in US$
Million by Drug Class: A Historic Review for the Period
2012-2019

Table 186: Israeli Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 187: Israeli Critical Care Therapeutics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 188: Critical Care Therapeutics Market in Israel:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 189: Israeli Critical Care Therapeutics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 190: Saudi Arabian Critical Care Therapeutics Market
Growth Prospects in US$ Million by Drug Class for the Period
2020-2027

Table 191: Critical Care Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Million by Drug Class: 2012-2019

Table 192: Saudi Arabian Critical Care Therapeutics Market by
Drug Class: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 193: Saudi Arabian Demand for Critical Care Therapeutics
in US$ Million by Application: 2020 to 2027

Table 194: Critical Care Therapeutics Market Review in Saudi
Arabia in US$ Million by Application: 2012-2019

Table 195: Saudi Arabian Critical Care Therapeutics Market
Share Breakdown by Application: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 196: Critical Care Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2020-2027

Table 197: United Arab Emirates Critical Care Therapeutics
Historic Market Analysis in US$ Million by Drug Class:
2012-2019

Table 198: Critical Care Therapeutics Market Share Distribution
in United Arab Emirates by Drug Class: 2012 VS 2020 VS 2027

Table 199: Critical Care Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2020-2027

Table 200: United Arab Emirates Critical Care Therapeutics
Historic Market Analysis in US$ Million by Application:
2012-2019

Table 201: Critical Care Therapeutics Market Share Distribution
in United Arab Emirates by Application: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 202: Critical Care Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Drug Class for the Period 2020-2027

Table 203: Rest of Middle East Critical Care Therapeutics
Historic Market Analysis in US$ Million by Drug Class:
2012-2019

Table 204: Rest of Middle East Critical Care Therapeutics
Market Share Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 205: Critical Care Therapeutics Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 206: Rest of Middle East Critical Care Therapeutics
Market in Retrospect in US$ Million by Application: 2012-2019

Table 207: Critical Care Therapeutics Market Share Distribution
in Rest of Middle East by Application: 2012 VS 2020 VS 2027

AFRICA
Table 208: African Critical Care Therapeutics Market Estimates
and Projections in US$ Million by Drug Class: 2020 to 2027

Table 209: Critical Care Therapeutics Market in Africa by Drug
Class: A Historic Review in US$ Million for 2012-2019

Table 210: African Critical Care Therapeutics Market Share
Breakdown by Drug Class: 2012 VS 2020 VS 2027

Table 211: African Critical Care Therapeutics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 212: Critical Care Therapeutics Historic Demand Patterns
in Africa by Application in US$ Million for 2012-2019

Table 213: Critical Care Therapeutics Market Share Breakdown in
Africa by Application: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 37
Read the full report: https://www.reportlinker.com/p05956486/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001